3 research outputs found

    The C-C model-derived survival curves for the nasopharyngeal carcinoma patients in the training set.

    No full text
    <p>The follow-up prognoses of the nasopharyngeal carcinoma patients in the training set were clearly identified by the four risk subgroups of the C-C model. (A) The overall survival curves for the L, IL, IH, and H risk subgroups of the C-C model; (B) The distant metastasis-free survival curves for the L, IL, IH, and H risk subgroups of the C-C model; (C) The progression-free survival curves for the L, IL, IH, and H risk subgroups of the C-C model; and (D) The local-regional recurrence-free survival curves for the L, IL, IH, and H risk subgroups of the C-C model. L, low-risk, nβ€Š=β€Š16; IL, intermediate-low-risk, nβ€Š=β€Š39; IH, intermediate-high-risk, nβ€Š=β€Š62; H, high-risk, nβ€Š=β€Š28.</p

    The C-C model-derived survival curves for the nasopharyngeal carcinoma patients in the testing set.

    No full text
    <p>The follow-up prognoses of the nasopharyngeal carcinoma patients in the testing set were clearly identified by the four risk subgroups of the C-C model. (A) The overall survival curves for the L, IL, IH, and H risk subgroups of the C-C model; (B) The distant metastasis-free survival curves for the L, IL, IH, and H risk subgroups of the C-C model; (C) The progression-free survival curves for the L, IL, IH, and H risk subgroups of the C-C model; and (D) The local-regional recurrence-free survival curves for the L, IL, IH, and H risk subgroups of the C-C model. L, low risk, nβ€Š=β€Š8; IL, intermediate-low risk, nβ€Š=β€Š38; IH, intermediate-high risk, nβ€Š=β€Š68; H, high risk, nβ€Š=β€Š31.</p

    The survival curves for the nasopharyngeal carcinoma patients with high/low serum CXCL5-levels in the training set.

    No full text
    <p>A high sCXCL5 level correlated with poor overall survival and distant metastasis-free survival rates in the training set patients. (A) The overall survival rate was significantly higher in the low sCXCL5 level patients; (B) The distant metastasis-free survival rate was significantly higher in the low sCXCL5 level patients. Low sCXCL5 level, nβ€Š=β€Š70; high sCXCL5 level, nβ€Š=β€Š75.</p
    corecore